A pharmacokinetic model for alpha interferon administered subcutaneously (Q36053393)

11 August 2017

A pharmacokinetic model for alpha interferon administered subcutaneously (English)

1 reference

11 August 2017

1 reference

E Chatelut

1

1 reference

11 August 2017

L Rostaing

2

1 reference

11 August 2017

N Grégoire

3

1 reference

11 August 2017

J L Payen

4

1 reference

11 August 2017

A Pujol

5

1 reference

11 August 2017

J Izopet

6

1 reference

11 August 2017

G Houin

7

1 reference

11 August 2017

P Canal

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

47

1 reference

11 August 2017

4

1 reference

11 August 2017

365-371

1 reference

A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Clinical study of recombinant DNA-produced leukocyte interferon (clone A) in a intermittent schedule in cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

A formula to estimate the approximate surface area if height and weight be known. 1916.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Clinical Pharmacokinetics of Interferons

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Prediction of creatinine clearance from serum creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Effect of obesity on pharmacokinetics and biologic effect of interferon-alpha in hepatitis C.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Some suggestions for measuring predictive performance

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014240

23 September 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2125.1999.00912.X

KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG

21 January 2018

1 reference

12 December 2020

Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection

1 reference

12 December 2020

Pharmacokinetics of interferon alpha-2b in healthy volunteers

1 reference

12 December 2020

Chronic viral hepatitis--benefits of current therapies

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00912.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

10233199

1 reference